Caxton Advantage Life Science Fund is a New York-based financial firm that invests into companies in the life-science field.
Business Model:
Revenue: $20M
Employees: 51-200
Address: 500 Park Ave
City: New York
State: NY
Zip: 10022
Country: US
Caxton Advantage Life Science Fund is a New York-based financial firm that invests into companies in the life-science field.
Contact Phone:
+12128911100
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
8/2014 | Mevion Medical Systems | Private Equity Round | 0 |
4/2010 | Gemin X Pharmaceuticals | Series D | 16M |
6/2013 | Mevion Medical Systems | Private Equity Round | 0 |
12/2007 | Corthera | Series C | 23M |
12/2009 | Regado Biosciences | Series D | 0 |
3/2007 | Regado Biosciences | Series C | 23M |
11/2020 | VIVUS | Post-IPO Equity | 33.6M |
1/2009 | Mevion Medical Systems | Venture Round | 33M |
7/2008 | Gemin X Pharmaceuticals | Series C | 38M |
10/2007 | Mevion Medical Systems | Series C | 6.9M |
8/2010 | Gemin X Pharmaceuticals | Series E | 8M |
4/2009 | Sunesis Pharmaceuticals | Post-IPO Equity | 0 |
8/2008 | Anthera Pharmaceuticals | Venture Round | 0 |
12/2012 | Regado Biosciences | Series E | 0 |
11/2020 | VIVUS | Post-IPO Equity | 0 |
8/2014 | Mevion Medical Systems | Private Equity Round | 0 |
6/2013 | Mevion Medical Systems | Private Equity Round | 0 |
12/2012 | Regado Biosciences | Series E | 0 |
8/2010 | Gemin X Pharmaceuticals | Series E | 0 |
4/2010 | Gemin X Pharmaceuticals | Series D | 0 |
12/2009 | Regado Biosciences | Series D | 0 |
4/2009 | Sunesis Pharmaceuticals | Post-IPO Equity | 0 |
1/2009 | Mevion Medical Systems | Venture Round | 0 |
8/2008 | Anthera Pharmaceuticals | Venture Round | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|